Development of a subgenomic clone system for Kyasanur Forest disease virus

Ticks Tick Borne Dis. 2016 Jul;7(5):1047-1051. doi: 10.1016/j.ttbdis.2016.06.002. Epub 2016 Jun 10.

Abstract

Emerging tropical viruses pose an increasing threat to public health because social, economic and environmental factors such as global trade and deforestation allow for their migration into previously unexposed populations and ecological niches. Among such viruses, Kyasanur Forest disease virus (KFDV) deserves particular recognition because it causes hemorrhagic fever. This work describes the completion of an antiviral testing platform (subgenomic system) for KFDV that could be used to quickly and safely screen compounds capable of inhibiting KFDV replication without the requirement for high containment, as the structural genes have been replaced with a luciferase reporter gene precluding the generation of infectious particles. The coordination of KFDV kinetics with the replication characteristics of the subgenomic system has provided additional insight into the timing of flavivirus replication events, as the genetically engineered KFDV genome began replication as early as 2h post cellular entry. Possession of such antiviral testing platforms by public health agencies should accelerate the testing of antiviral drugs against emerging or recently emerged viruses mitigating the effects of their disease and transmission.

Keywords: Antiviral research; Flavivirus; Kyasanur Forest disease virus; Molecular genetics; Subgenomic clone system; Tick-borne flavivirus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • Encephalitis Viruses, Tick-Borne / genetics*
  • Encephalitis Viruses, Tick-Borne / physiology*
  • Flavivirus / genetics
  • Genes, Reporter
  • Genome, Viral*
  • Hemorrhagic Fevers, Viral / diagnosis
  • High-Throughput Screening Assays
  • Luciferases / genetics
  • Replicon
  • Virus Replication* / drug effects
  • Virus Replication* / genetics

Substances

  • Antiviral Agents
  • Luciferases